WGS of the genomes of TAM, AMKL, and DS-AMKL patients. Progression to DS-AMKL required acquisition of further mutations, including RAD21, STAG2, NRAS, CTCF, EZH2, and TP53. This evidence concerns the gene CTCF and acute megakaryoblastic leukemia.